Article Details

Generex Biotechnology Corporation (OTCMKTS:GNBT) Completes immunogenicity Trial in mice

Retrieved on: 2021-03-08 08:37:30

Tags for this article:

Click the tags to see associated articles and topics

Generex Biotechnology Corporation (OTCMKTS:GNBT) Completes immunogenicity Trial in mice. View article details on hiswai:

Excerpt

A complete vaccine regulates the immune system for a neutralizing and targeted antibody response. President of Generex, Joseph Moscato, said the ...

Article found on: www.mmjreporter.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up